The European Sepsis Academy (ESA-ITN) aims to develop and validate the pathological insights, biomarker diagnostics and clinical trial models that can enable development and implementation of personalised treatment strategies targeted at the immunosuppressive phase of sepsis. ESA-ITN Is an international project (including partners in 10 countries) and offers an extensive sepsis-oriented joint training programme to PhD students which are also called early-stage researchers (ESRs) within this programme. The individual research projects are embedded in leading institutes and companies in the field. Additionally, a spectrum of courses and training opportunities at different levels will allow the ESRs to master advanced research methodologies and technologies that are crucial for sepsis research, make use of state-of-the-art infrastructure and work directly with leading experts in one of the focal fields. Furthermore, ESRs will be trained in generally applicable skills that are crucial in science and business such as data presentation, grant writing and scientific language/writing in English, but also management courses. This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 676129. This website reflects only the author's view and the European Commission is not responsible for any use that may be made of the information it contains